Immunogenicity and reactogenicity of a first booster with BNT162b2 or full-dose mRNA-1273: A randomised VACCELERATE trial in adults ≥75 years (EU-COVAT-1).

Neuhann JM, Stemler J, Carcas AJ, Frías-Iniesta J, Akova M, Bethe U, Heringer S, Salmanton-García J, Tischmann L, Zarrouk M, Cüppers A, Grothe J, Leon AG, Mallon P, Negi R, Gaillard C, Saini G, Lammens C, Hotterbeekx A, Loens K, Malhotra-Kumar S, Goossens H, Kumar-Singh S, König F, Yeghiazaryan L, Posch M, Koehler P, Cornely OA

Open source

DOI: 10.1016/j.vaccine.2023.10.029
Published: 2023 Nov 22
Container: Vaccine
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.vaccine.2023.10.029,
  title = {Immunogenicity and reactogenicity of a first booster with BNT162b2 or full-dose mRNA-1273: A randomised VACCELERATE trial in adults ≥75 years (EU-COVAT-1).},
  author = {Neuhann JM and Stemler J and Carcas AJ and Frías-Iniesta J and Akova M and Bethe U and Heringer S and Salmanton-García J and Tischmann L and Zarrouk M and Cüppers A and Grothe J and Leon AG and Mallon P and Negi R and Gaillard C and Saini G and Lammens C and Hotterbeekx A and Loens K and Malhotra-Kumar S and Goossens H and Kumar-Singh S and König F and Yeghiazaryan L and Posch M and Koehler P and Cornely OA},
  year = {2023},
  journal = {Vaccine},
  doi = {10.1016/j.vaccine.2023.10.029},
  url = {https://doi.org/10.1016/j.vaccine.2023.10.029}
}

RIS

TY  - JOUR
TI  - Immunogenicity and reactogenicity of a first booster with BNT162b2 or full-dose mRNA-1273: A randomised VACCELERATE trial in adults ≥75 years (EU-COVAT-1).
AU  - Neuhann JM
AU  - Stemler J
AU  - Carcas AJ
AU  - Frías-Iniesta J
AU  - Akova M
AU  - Bethe U
AU  - Heringer S
AU  - Salmanton-García J
AU  - Tischmann L
AU  - Zarrouk M
AU  - Cüppers A
AU  - Grothe J
AU  - Leon AG
AU  - Mallon P
AU  - Negi R
AU  - Gaillard C
AU  - Saini G
AU  - Lammens C
AU  - Hotterbeekx A
AU  - Loens K
AU  - Malhotra-Kumar S
AU  - Goossens H
AU  - Kumar-Singh S
AU  - König F
AU  - Yeghiazaryan L
AU  - Posch M
AU  - Koehler P
AU  - Cornely OA
PY  - 2023
JO  - Vaccine
DO  - 10.1016/j.vaccine.2023.10.029
UR  - https://doi.org/10.1016/j.vaccine.2023.10.029
ER  -

APA

JM, N., J, S., AJ, C., J, F., M, A., U, B., S, H., J, S., L, T., M, Z., A, C., J, G., AG, L., P, M., R, N., C, G., G, S., C, L., A, H., K, L., S, M., H, G., S, K., F, K., L, Y., M, P., P, K., & OA, C. (2023). Immunogenicity and reactogenicity of a first booster with BNT162b2 or full-dose mRNA-1273: A randomised VACCELERATE trial in adults ≥75 years (EU-COVAT-1).. Vaccine. https://doi.org/10.1016/j.vaccine.2023.10.029

Source records

pubmed · retrieved 2026-09-26T09:32:27.250Z